Evaluating the vaccine potential of an influenza A viral hemagglutinin and matrix double insertion DNA plasmid

Vaccine

Volumn 25, Issue 44, 2007, Pages 7649-7655

  Xie, Hang ^a   Liu, Teresa ^a   Chen, Hong ^a   Huang, Xiaoyuan ^a   Ye, Zhiping ^a  

^a Office of Biologics Research and Review   (United States)

Author keywords

DNA vaccine; Influenza; T cell

Indexed keywords

CD69 ANTIGEN; CD8ALPHA ANTIGEN; DNA VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INFLUENZA VIRUS HEMAGGLUTININ PLUS MATRIX PROTEIN 1 VACCINE; MATRIX PROTEIN; PLASMID DNA; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; GENE EXPRESSION; GENE INSERTION; HUMORAL IMMUNITY; INFLUENZA; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNIZATION; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; PLASMIDS; VACCINES, DNA; VIRAL MATRIX PROTEINS;

EID: 35048816461     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.08.052     Document Type: Article

References (20)

1. Ali A., and Nayak D.P. Assembly of Sendai virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein. Virology 276 (2000) 289-303
2. Ali A., Avalos R.T., Ponimaskin E., and Nayak D.P. Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein. J Virol 74 (2000) 8709-8719
3. Barman S., Ali A., Hui E.K., Adhikary L., and Nayak D.P. Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses. Virus Res 77 (2001) 61-69
4. Chen B.J., Takeda M., and Lamb R.A. Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly. J Virol 79 (2005) 13673-13684
5. Chen Z., Matsuo K., Asanuma H., Takahashi H., Iwasaki T., Suzuki Y., et al. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine 17 (1999) 653-659
6. Deng Y., Yewdell J.W., Eisenlohr L.C., and Bennink J.R. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J Immunol 158 (1997) 1507-1515
7. Donnelly J.J., Friedman A., Martinez D., Montgomery D.L., Shiver J.W., Motzel S.L., et al. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat Med 1 (1995) 583-587
8. Egorina E., Sovershaev M.A., Bjørkøy G., Gruber F.X.E., Olsen J.O., Parhami-Seren B., et al. Intracellular and surface distribution of monocyte tissue factor, application to intersubject variability. Arterioscler Thromb Vasc Biol 25 (2005) 1-7
9. Epstein S.L., Stack A., Misplon J.A., Lo C.Y., Mostowski H., Bennink J., et al. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge. Int Immunol 12 (2000) 91-101
10. Forde G.M. Rapid-response vaccines-does DNA offer a solution?. Nat Biotechnol 23 (2005) 1059-1062
11. Gomez-Puertas P., Albo C., Perez-Pastrana E., Vivo A., and Portela A. Influenza virus matrix protein is the major driving force in virus budding. J Virol 74 (2000) 11538-11547
12. Gonzales Bosc L.V., Layne J.J., Nelson M.T., and Hill-Eubanks D.C. Nuclear factor of activated T cells and serum response factor cooperatively regulate the activity of an α-actin intronic enhancer. J Biol Chem 280 (2005) 26113-26120
13. + T cells specific for influenza A virus M1 display broad expression of maturation-associated phenotypic markers and chemokine receptors. Immunology 115 (2005) 239-245
14. Latham T., and Galarza J.M. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol 75 (2001) 6154-6165
15. Liu T., Muller J., and Ye Z. Association of influenza virus matrix protein with ribonucleoproteins may control viral growth and morphology. Virology 304 (2002) 89-96
16. Liu T., and Ye Z. Restriction of viral replication by mutation of the influenza virus matrix protein. J Virol 76 (2002) 13055-13061
17. Okuda K., Ihata A., Watabe S., Okada E., Yamakawa T., Hamajima K., et al. Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene. Vaccine 19 (2001) 3681-3691
18. + T cells. J Immunol 171 (2003) 1999-2005
19. Ozaki T., Yauchi M., Xin K.Q., Hirahara F., and Okuda K. Cross-reactive protection against influenza A virus by a topically applied DNA vaccine encoding M gene with adjuvant. Viral Immunol 18 (2005) 373-380
20. Stech J., Garn H., Wegmann M., Wagner R., and Klenk H.D. A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin. Nat Med 11 (2005) 683-689